| |
|
|
|
Therapix Biosciences Ltd.  
|
|
3.3511 -0.039 (-0.01%) |
07-19 14:23 |
|
Open: |
3.39 |
Pre close: |
3.39 |
Target:
|
4.72 
|
|
High: |
3.3986 |
Low: |
3.2 |
Resistance:
|
4.04
4.68
|
|
Volume: |
18,683 |
Market Cap: |
12M |
Support:
|
3.00
2.50
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
3.28
|
MACD |
MACD(12,26):
|
-0.27  |
|
MA(20): |
3.72 |
Signal(12,26,9): |
-0.24 |
|
MA(100): |
4.65 |
Stochastic Oscillator |
%K(14,3):
|
25.33 |
|
MA(250): |
5.23 |
%D(3): |
19.92 |
|
Average Volume(K) |
3-Month: |
2744
|
52-Week |
High:
|
7.69 |
|
10-Days: |
6283 |
Low: |
3.00 |
|
RSI |
RSI(14):
|
37.56 |
Change(%): |
-49.8 |
|
Financials, Statistics and Valuation |
|
EPS |
0.000 |
Return on Equity (ttm) |
-122.8 |
Shares Out. (M) |
3.50 |
|
EPS Est. Current Year |
-1.520 |
Return on Assets (ttm) |
-95.1 |
Shares Float (M) |
3.50 |
|
EPS Est. Next Year |
-2.130 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
-0.550 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
0.40 |
|
Forward EPS |
-2.158 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
168 |
|
Book Value (p.s.) |
1.900 |
EBITDA (p.s.) |
0.000 |
P/E |
0.00 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
1.74 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-6.01 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
0.00 |
P/CF |
-1.92 |
|
|
|
|
|
|
